300406.SZ SHZ
Beijing Strong Biotechnologies, Inc.
1W: +1.3%
1M: +3.2%
3M: +6.5%
YTD: -10.4%
1Y: -17.1%
3Y: -39.8%
5Y: -29.5%
¥11.94 ($1.78)
+0.17 (+1.44%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$614M
+4.9% ▲
5Y CAGR: +26.6%
Capital Expenditures
$68M
+54.3% ▲
5Y CAGR: +2.0%
Free Cash Flow
$546M
+25.0% ▲
5Y CAGR: +33.8%
Dividends Paid
$124M
-111.9% ▼
Buybacks
$45M
+9.7% ▲
Net Change in Cash
$419M
+9.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $122M | $470M | $394M | $524M | $531M |
| Depreciation & Amort. | $30M | $44M | $55M | $57M | $71M |
| Stock-Based Comp. | $640K | $35M | $7M | $0 | $0 |
| Change in Working Capital | -$75M | -$219M | -$137M | -$54M | -$32M |
| Other Non-Cash Items | $47M | $47M | $84M | $73M | $44M |
| Operating Cash Flow | $123M | $341M | $396M | $590M | $614M |
| — Investing Activities — | |||||
| Capital Expenditures | -$17M | -$65M | -$96M | -$148M | -$68M |
| Acquisitions (Net) | -$1.1B | $225K | -$1M | $1M | $0 |
| Investment Purchases | -$55M | -$1.6B | -$479M | -$336M | -$623M |
| Investment Sales | $88M | $334M | $149M | $351M | $571M |
| Other Investing | $341K | $0 | -$12M | -$268K | $101M |
| Investing Cash Flow | -$1.1B | -$1.3B | -$441M | -$132M | -$19M |
| — Financing Activities — | |||||
| Net Debt Issuance | $216M | $821M | $138M | $5M | -$9M |
| Stock Repurchased | $0 | $0 | -$51M | -$49M | -$45M |
| Dividends Paid | -$75M | -$58M | -$59M | -$59M | -$124M |
| Other Financing | $1.2B | $34M | -$7M | -$21M | $888K |
| Financing Cash Flow | $1.3B | $777M | -$11M | -$75M | -$176M |
| Net Change in Cash | $352M | -$195M | -$54M | $383M | $419M |
| Cash End of Period | $577M | $383M | $328M | $712M | $1.1B |
| Free Cash Flow | $106M | $276M | $300M | $437M | $546M |